UAE Next Generation Sequencing Market to grow with a CAGR of 14.83%
Increasing healthcare infrastructure and a supportive regulatory environment are the major drivers for the UAE Next Generation Sequencing Market.
According to TechSci Research report, “UAE
Next Generation Sequencing Market Industry
Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028”, UAE Next Generation Sequencing Market
has valued at USD 0.13 billion in 2022 and is anticipated to witness an
impressive growth in the forecast period with a CAGR of 14.83% through 2028.
This can be due to collaborations
and partnerships among leading companies with a diverse approach to merge the
expertise of individual companies and to strengthen their position in the
market.
The field of bioinformatics and data
analysis solutions plays a pivotal role in driving the demand for Next
Generation Sequencing (NGS). NGS
generates vast amounts of data in the form of raw sequencing reads.
Bioinformatics tools are essential for processing, filtering, and managing
these large datasets efficiently. Bioinformatics
solutions are crucial for assembling short sequencing reads into complete
genomes and mapping them to reference genomes. This is fundamental for
understanding the genomic structure and identifying variations. Identifying genetic variants, such as
single nucleotide polymorphisms (SNPs) and insertions/deletions (indels), is a
key aspect of NGS data analysis. Bioinformatics tools are used for variant
calling, and annotating these variants provides insights into their potential
functional significance.
Bioinformatics enables the analysis of
functional genomics data, including the identification of genes, regulatory
elements, and pathways implicated in specific biological processes. This is
essential for understanding the functional implications of genomic variations.
NGS data analysis involves the
detection of structural variants, such as copy number variations (CNVs) and
chromosomal rearrangements. Bioinformatics tools are used to identify and
interpret these structural variations.
Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on " UAE Next Generation Sequencing Market.”
In March 2023, The UAE has
initiated its National Genome Strategy, designed to establish a thorough
legislative and governance framework facilitating the creation and execution of
genomic programs. Spanning a decade, the strategy aims to address public health
priorities and enhance the nation's overall well-being. Oversight for the
National Genome Strategy is vested in the Emirates Genome Council, formed in
2021, which has made substantial strides in establishing the foundation for
regulatory, research, technological, and medical institutions to foster
connectivity, collaboration, and the development of advanced medical
applications and services.
Patient
consent and engagement represent crucial aspects of ethical and legal
considerations in the Next Generation Sequencing (NGS) market. In the United
Arab Emirates (UAE), as in many other regions, there are several challenges
related to obtaining informed consent from patients and engaging them
effectively in the context of genomic testing. Patients may express
concerns about the privacy and security of their genetic information. The
sensitive nature of genomic data raises apprehensions about how the information
will be handled, stored, and protected from unauthorized access. NGS
involves complex technologies and potential implications for patients and their
families. Explaining the intricacies of NGS procedures, potential findings, and
the long-term impact of genomic data may be challenging, making it difficult
for patients to provide truly informed consent. Cultural factors play a
significant role in patient perceptions and decision-making. There may be
cultural sensitivities in discussing genetic information, and healthcare
providers need to navigate these cultural nuances to ensure effective
communication and consent.
UAE Next Generation
Sequencing Market is segmented based on Product, Technology, Application, End
User, and by region.
Based on Technology, Sequencing
by Synthesis, lon Semiconductor Sequencing, Sequencing by Ligation, Single
Molecule Real Time Sequencing, Others. Single Molecule Real Time Sequencing
(SMRT Sequencing) is a third-generation sequencing technology developed by
Pacific Biosciences (PacBio). Unlike traditional sequencing methods that rely
on the detection of fluorescence signals during polymerization reactions, SMRT
Sequencing directly observes the incorporation of nucleotides in real time from
a single DNA molecule. This technology offers long read lengths and is known
for its ability to generate highly accurate sequencing data. SMRT Sequencing utilizes
a unique platform called Zero-Mode Waveguide (ZMW) arrays. ZMWs are tiny wells,
each of which contains a single DNA polymerase enzyme immobilized at the
bottom. The diameter of these wells is such that only a single DNA polymerase
enzyme and its associated template DNA strand can fit inside.
Based on Region, Abu Dhabi region held the largest share
in the UAE Next Generation Sequencing Market. The
strategic location and economic factors, such as a stable economic environment
and business-friendly policies, can attract investment and companies
specializing in NGS technologies to operate in the region. Educational programs
and training initiatives that focus on genomics and NGS technologies can
contribute to the development of a skilled workforce. If Abu Dhabi has invested
in such programs, it may enhance its capabilities in the NGS field. A
supportive and clear regulatory environment for genomics and NGS applications
can encourage businesses and research institutions to operate in a region. If
Abu Dhabi has established favorable regulatory conditions, it may attract
stakeholders in the NGS market.
Some of the major companies operating in
the UAE Next
Generation Sequencing Market include:
- Oxford
Nanopore UAE
- Agiomix
Labs
- Illumina
UAE
- Thermo
Fischer Scientific UAE
- PerkinElmer
UAE
- Alliance
Global UAE
Download free Sample Report
Customers
can also request 10% free customization on this report.
“Certain areas,
particularly in Dubai, are projected to exert significant demand for Next
Generation Sequencing. The growth in the competitive landscape and the presence
of well-established companies in the market, committed to enhance the overall
wellbeing of people each year, are expected to contribute to a remarkable
growth of the UAE Next Generation Sequencing Market in the forecast period,"
said Mr. Karan Chechi, Research Director with TechSci Research, a
research-based Global management consulting firm.
UAE Next Generation
Sequencing Market by Product (Consumables, Platforms, Services), By Technology
(Sequencing by Synthesis, lon Semiconductor Sequencing, Sequencing by Ligation,
Single Molecule Real Time Sequencing, Others), By Application (Biomarkers &
Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Agriculture
& Animal Research, Others), By End User (Academic & Clinical Research
Centers, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics,
Others), By Region, By Competition Forecast & Opportunities, 2018-2028F has evaluated the future growth potential of UAE
Next Generation Sequencing Market and provides statistics & information on
market size, structure, and future market growth. The report intends to provide
innovative market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in UAE Next
Generation Sequencing Market.
Contact
Mr. Ken
Mathews
Techsci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
M:
+13322586602
Email: [email protected]
Website: https://www.techsciresearch.com